Research progress in the application of ivabradine in children with cardiovascular diseases

doi:10.7499/j.issn.1008-8830.2401072

Home > Archive>Volume , Issue 7, 2024 >782-788. DOI:10.7499/j.issn.1008-8830.2401072

Research progress in the application of ivabradine in children with cardiovascular diseases
DOI:
                        10.7499/j.issn.1008-8830.2401072
                    
CSTR:
                        
Author:
                        
Affiliation:Department of Cardiology, Children's Hospital of Chongqing Medical University/National Key Clinical Specialty/Ministry of Education Key Laboratory of Child Development and Disorders/National Clinical Research Center for Child Health and Disorders/China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing 400014, China
Clc Number:
Fund Project:

Article

Figures

Metrics

Reference

Cited by

Materials

Comments

Abstract:

Ivabradine, as a specific I_f current inhibitor, has been widely used in the treatment of chronic heart failure in adults due to its ability to reduce heart rate without affecting myocardial contractility and blood pressure. It has also shown good effects in various types of tachyarrhythmias. However, the application of ivabradine in pediatric cardiovascular diseases still faces many limitations. This article reviews the current research progress on the use of ivabradine in treating pediatric cardiovascular diseases both domestically and internationally, aiming to provide guidance for pediatric cardiologists. Citation:Chinese Journal of Contemporary Pediatrics, 2024, 26(7): 782-788

Reference

Cited by

Get Citation

蒋露,孙慧超.伊伐布雷定在儿童心血管疾病中的应用进展[J].中国当代儿科杂志英文版,2024,(7):782-788

Copy

Article Metrics

Abstract:
PDF:
HTML:
Cited by:

History

Received:January 15,2024
Revised:
Adopted:
Online: January 14,2025
Published:

Get Citation

Share

Article Metrics

History

Article QR Code